Skip to Main Content

Author Details

Guillaume Charpentier
1980
186
55
PMIDPaper TitleJournal TitlePublished Year
34658265Hybrid Closed-Loop Control with Ultrarapid Lispro Compared with Standard Insulin Aspart and Faster Insulin Aspart: An In Silico Study.Journal of diabetes science and technology2023
37729499Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378.2023
37709961Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity.Nat Metab2023
38051360Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.2023
37858921Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment.2023
36822744Contribution of heterozygous PCSK1 variants to obesity and implications for precision medicine: a case-control study.2023
36751978One-year real-world performance of the DBLG1 closed-loop system: Data from 3706 adult users with type 1 diabetes in Germany.2023
37449762First Generation of a Modular Interoperable Closed-Loop System for Automated Insulin Delivery in Patients With Type 1 Diabetes: Lessons From Trials and Real-Life Data.2023
37520145Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study.2023
35099098The beneficial effects of closed-loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: An extension study of the DBLHU-WP10 trial.Diabetes, Obesity and Metabolism2022
36172702Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System.Journal of diabetes science and technology2022
35604800Management of Pregnancy in a Patient with Type 1 Diabetes and Hypoglycemia Unawareness by DBL-hu Closed-Loop Insulin Delivery System.Diabetes Technology and Therapeutics2022
36556977Intact Fish Skin Graft vs. Standard of Care in Patients with Neuroischaemic Diabetic Foot Ulcers (KereFish Study): An International, Multicentre, Double-Blind, Randomised, Controlled Trial Study Design and Rationale.2022
34853028Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes.Diabetes Care2022
35216750Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial.Lancet Digital Health, The2022
34666166Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch.2022
34661078Identification of Key Regions Mediating Human Melatonin Type 1 Receptor Functional Selectivity Revealed by Natural Variants.ACS Pharmacol Transl Sci2021
34009725No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12â¿¿weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial.Diabetes, Obesity and Metabolism2021
34272606Prospective analysis of satisfaction and usability of closed-loop Diabeloop DBLHU treatment in patients with highly unstable type 1 diabetes.Acta Diabetologica2021
33001536Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed-loop insulin delivery system: A series of N-of-1 randomized controlled trials.Diabetes, Obesity and Metabolism2021
33431420Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up.Diabetes Care2021
33162895Circadian, Sleep and Caloric Intake Phenotyping in Type 2 Diabetes Patients With Rare Melatonin Receptor 2 Mutations and Controls: A Pilot Study.Front Physiol2020
31960258Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes.Drugs2020
32407148DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen.Diabetes Technology and Therapeutics2020
31621186Efficacy of the Diabeloop closed-loop system to improve glycaemic control in patients with type 1 diabetes exposed to gastronomic dinners or to sustained physical exercise.Diabetes, Obesity and Metabolism2020
32383100Télépied Study: A Single-Centre Trial in Diabetic Subjects Comparing Total Duration of Hospitalization Over a 1-Year Period Required for Complete Healing of a Foot Ulcer Using Telemedicine Management and a Referral Nurse Versus the Standard Care Pathway.Diabetes Therapy2020
33046911Pathogenic variants in actionable MODY genes are associated with type 2 diabetes.Nat Metab2020
33019132Increasing the safety of unannounced meal detection for artificial pancreas closed-loop with patient's hourly meal schedule.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2020
32958628Comment on Leelarathna et al. Duration of Hybrid Closed-Loop Insulin Therapy to Achieve Representative Glycemic Outcomes in Adults With Type 1 Diabetes. Diabetes Care 2020;43:e38-e39.Diabetes Care2020
30862245Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.Journal of diabetes science and technology2019
31700171Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension.Nature Medicine2019
31947092Modeling the variability of insulin sensitivity for people with Type 1 Diabetes based on clinical data from an artificial pancreas study.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2019
33323237Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.Lancet Digital Health, The2019
30646755A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes.Journal of diabetes science and technology2019
31173451Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab-2 randomized controlled trial.Diabetes, Obesity and Metabolism2019
29191980Prior automatic posture and activity identification improves physical activity energy expenditure prediction from hip-worn triaxial accelerometry.Journal of Applied Physiology2018
29766634Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.Diabetes, Obesity and Metabolism2018
29674306DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial.JMIR Research Protocols2018
29174479Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.2018
29520615Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study.Acta Diabetologica2018
29246950Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.Diabetes Care2018
28138803Effectiveness and Persistence of Liraglutide Treatment Among Patients with Type 2 Diabetes Treated in Primary Care and Specialist Settings: A Subgroup Analysis from the EVIDENCE Study, a Prospective, 2-Year Follow-up, Observational, Post-Marketing Study.Advances in Therapy2017
28684227Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control.2017
28665293An original piecewise model for computing energy expenditure from accelerometer and heart rate signals.Physiological Measurement2017
28566273An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans.Diabetes2017
29060152Personalization of a compartmental physiological model for an artificial pancreas through integration of patient's state estimation.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference2017
27837286Is there evidence of potential overtreatment of glycaemia in elderly people with type 2 diabetes? Data from the GUIDANCE study.Acta Diabetologica2017
27526329Insulin Infusion Set Use: European Perspectives and Recommendations.Diabetes Technology and Therapeutics2016
26486355Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes.Diabetologia2016
26528939In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin.Mol Ther Nucleic Acids2015
  • 1 - 50 of 186

Recommended Authors

Collaborators

Co-authored papers 62
Co-authored papers 46
Co-authored papers 38
Co-authored papers 23
Co-authored papers 20
Co-authored papers 20
Co-authored papers 19
Co-authored papers 18
Co-authored papers 18
Co-authored papers 16
Co-authored papers 15
Co-authored papers 15
Co-authored papers 15
Co-authored papers 13
Co-authored papers 12
Co-authored papers 12
Co-authored papers 11
University of Iceland
Co-authored papers 11
Co-authored papers 11
Broad Institute of Harvard and Massachusetts Institute of Technology (MIT)
Co-authored papers 11
deCODE genetics/Amgen Inc.
Co-authored papers 11
Co-authored papers 11
University of Edinburgh
Co-authored papers 11
The University of Manchester
Co-authored papers 11
Pat Macpherson Centre for Pharmacogenomics and Pharmacogenetics, University of Dundee
Co-authored papers 11
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 11
Co-authored papers 11
Co-authored papers 11
Co-authored papers 11
Co-authored papers 11